Chesnara plc (LON:CSN – Get Free Report) insider David Rimmington sold 24,902 shares of the company’s stock in a transaction dated Tuesday, April 30th. The shares were sold at an average price of GBX 252 ($3.17), for a total transaction of £62,753.04 ($78,825.57).
Chesnara Stock Performance
Shares of CSN traded down GBX 2.50 ($0.03) during trading hours on Tuesday, reaching GBX 252 ($3.17). 463,347 shares of the company traded hands, compared to its average volume of 152,458. The stock’s fifty day moving average is GBX 260.06 and its 200 day moving average is GBX 260.44. The stock has a market cap of £380.14 million, a P/E ratio of -748.53 and a beta of 0.39. The company has a debt-to-equity ratio of 58.24, a quick ratio of 38.06 and a current ratio of 2.38. Chesnara plc has a 1-year low of GBX 242.70 ($3.05) and a 1-year high of GBX 290 ($3.64).
Chesnara Increases Dividend
The business also recently disclosed a dividend, which will be paid on Tuesday, May 28th. Stockholders of record on Thursday, April 11th will be given a dividend of GBX 15.61 ($0.20) per share. The ex-dividend date is Thursday, April 11th. This represents a dividend yield of 5.96%. This is a positive change from Chesnara’s previous dividend of $8.36. Chesnara’s dividend payout ratio is currently -7,058.82%.
About Chesnara
Chesnara plc, together with its subsidiaries, operates in life assurance and pension businesses primarily in the United Kingdom, the Netherlands, and Sweden. It operates through UK, Movestic, Waard Group, and Scildon segments. The company underwrites life risks, such as death, disability, health, and accident; and provides a portfolio of investment contracts for the savings and retirement needs of customers through asset management, as well as general insurance products.
See Also
- Five stocks we like better than Chesnara
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- NXP Semiconductors Will Set a New High Soon: $300 in Sight
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- Hilton Demonstrates Asset Light is Right for Investors
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Boston Scientific Bucks the Medtech Slow Down and Raises Outlook
Receive News & Ratings for Chesnara Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chesnara and related companies with MarketBeat.com's FREE daily email newsletter.